Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMP | P19971 | 7/20 | 0.62 |
| ▸ | HINT1 | P49773 | 7/20 | 0.51 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | GSK3A | P49840 | 2/20 | 0.47 |
| ▸ | RPS6KA3 | P51812 | 2/20 | 0.47 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.47 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.47 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.47 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.45 |
| ▸ | NT5E | P21589 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL313747 | 0.95 | TYMP (0.62) | TYMPHINT1HPGDGSK3ARPS6KA3 | |
| SCHEMBL313746 | 0.95 | TYMP (0.62) | TYMPHINT1HPGDGSK3ARPS6KA3 | |
| SCHEMBL6420722 | 0.88 | TYMP (0.79) | TYMPHINT1HPGDGSK3ARPS6KA3 | |
| SCHEMBL8958859 | 0.87 | TYMP (0.64) | TYMPHINT1HPGDGSK3ARPS6KA3 | |
| SCHEMBL5960204 | 0.87 | TYMP (0.69) | TYMPHINT1HPGDGSK3ARPS6KA3 | |
| SCHEMBL18042134 | 0.86 | TYMP (0.68) | TYMPHINT1HPGDGSK3ARPS6KA3 | |
| SCHEMBL1738400 | 0.86 | TYMP (0.68) | TYMPHINT1HPGDGSK3ARPS6KA3 | |
| SCHEMBL16702978 | 0.86 | TYMP (0.68) | TYMPHINT1HPGDGSK3ARPS6KA3 | |
| SCHEMBL21905181 | 0.85 | TYMP (0.67) | TYMPHINT1HPGDGSK3ARPS6KA3 | |
| SCHEMBL28827051 | 0.84 | TYMP (0.65) | TYMPHINT1HPGDGSK3ARPS6KA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030087871-A1 | Antisense modulation of caspase 9 expression | ISIS PHARMACEUTICALS, INC. | 2003-05-08 | — | — | US | disclosed |
| EP-0977767-A4 | AMINOOXY-MODIFIED OLIGONUCLEOTIDES | ISIS PHARMACEUTICALS INC (US) | 2003-04-23 | — | — | EP | disclosed |
| EP-0977767-A1 | AMINOOXY-MODIFIED OLIGONUCLEOTIDES | ISIS PHARMACEUTICALS, INC. (US) | 2000-02-09 | — | — | EP | disclosed |
| WO-1998035978-A1 | AMINOOXY-MODIFIED OLIGONUCLEOTIDES | ISIS PHARMACEUTICALS, INC. (US) | 1998-08-20 | — | — | WO | disclosed |